as of 11-02-2026 11:07am EST
Covista Inc is America's healthcare educator across five accredited institutions: Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. It delivers education to its students at multiple campuses and online. Its segments are Chamberlain, Walden, and Medical and Veterinary. Walden generates maximum revenue and includes the operations of Walden, which offers degree and certificate programs, including those in nursing, education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Company generates maximum revenue from Domestic operations.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 4.3B | IPO Year: | 1995 |
| Target Price: | $159.00 | AVG Volume (30 days): | 275.5K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | quarterly |
| EPS: | 1.95 | EPS Growth: | 13.92 |
| 52 Week Low/High: | $96.08 - $142.13 | Next Earning Date: | 10-29-2026 |
| Revenue: | $1,954,085,000 | Revenue Growth: | 9.27% |
| Revenue Growth (this year): | 6.45% | Revenue Growth (next year): | 7.00% |
| P/E Ratio: | 64.21 | Index: | |
| Free Cash Flow: | 392.7M | FCF Growth: | +9.73% |
Chairman & CEO
Avg Cost/Share
$130.77
Shares
4,667
Total Value
$610,298.92
Owned After
469,158
SEC Form 4
Chairman & CEO
Avg Cost/Share
$130.37
Shares
3,639
Total Value
$474,412.79
Owned After
469,158
SEC Form 4
VP, Chief Accounting Officer
Avg Cost/Share
$137.18
Shares
1,802
Total Value
$247,198.36
Owned After
5,083
SEC Form 4
Chairman & CEO
Avg Cost/Share
$130.35
Shares
3,545
Total Value
$462,073.03
Owned After
469,158
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$135.15
Shares
2,186
Total Value
$295,437.90
Owned After
48,306
SEC Form 4
SVP, GC, Corp. Sec & ISS
Avg Cost/Share
$135.81
Shares
4,526
Total Value
$614,676.06
Owned After
28,544
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Beard, Stephen W. | CVSA | Chairman & CEO | Oct 9, 2026 | Sell | $130.77 | 4,667 | $610,298.92 | 469,158 | |
| Beard, Stephen W. | CVSA | Chairman & CEO | Oct 8, 2026 | Sell | $130.37 | 3,639 | $474,412.79 | 469,158 | |
| Gangadharan Manjunath | CVSA | VP, Chief Accounting Officer | Aug 27, 2026 | Sell | $137.18 | 1,802 | $247,198.36 | 5,083 | |
| Beard, Stephen W. | CVSA | Chairman & CEO | Aug 11, 2026 | Sell | $130.35 | 3,545 | $462,073.03 | 469,158 | |
| Phelan Robert J. | CVSA | Chief Financial Officer | Aug 7, 2026 | Sell | $135.15 | 2,186 | $295,437.90 | 48,306 | |
| BECK DOUGLAS G. | CVSA | SVP, GC, Corp. Sec & ISS | Aug 7, 2026 | Sell | $135.81 | 4,526 | $614,676.06 | 28,544 |
SEC 8-K filings with transcript text
Oct 29, 2026
2 cvsa-ex99d1.htm
Exhibit 99.1
Investor Contact: Jeremy Cohen
Investor.Relations@Covista.com
Media Contact: Nick Lucido
CovistaMedia@Covista.com
Covista Reports First Quarter Fiscal Year 2027 Results; Raises Fiscal Year 2027 Revenue and Adjusted EPS Guidance
Total enrollment up 7.6% YoY
Revenue up 10.7% YoY
Diluted earnings per share $1.95; Adjusted EPS $2.19, growth of 25.1% YoY
Chief Financial Officer Robert Phelan announces planned retirement; will continue to serve until a successor is named
First quarter highlights
●Total student enrollment of 104,713, up 7.6% year-over-year, achieved 13th straight quarter of growth
●Revenue of $511.5 million, up 10.7% year-over-year
●Chamberlain University achieved 3rd straight quarter of total enrollment growth and achieved 17th straight quarter of pre-licensure BSN total enrollment growth
●Walden University achieved 13th straight quarter of total enrollment growth, up 12.8% year-over-year, highest total enrollment in university history
●Medical and Veterinary delivered total enrollment growth of 3.5% year-over-year
●GAAP net income $67.4 million; adjusted EBITDA $131.2 million, up 17.1% year-over-year
Capital allocation
●Repurchased $84 million of shares in the first quarter
●Net leverage of 0.5x as of Sep. 30, 2026
●Repriced our $510 million Term Loan B, reducing the interest rate margin by 25 basis points to SOFR plus 2.00%
Increased fiscal year 2027 guidance
●Revenue in the range of $2,060 million to $2,095 million, or approximately 5.5% to 7% growth year-over-year, and from a previous range of $2,050 million to $2,090 million
●Adjusted earnings per share in the range of $9.00 to $9.20, or approximately 9% to 11.5% growth year-over-year, and from a previous range of $8.90 to $9.15
CHICAGO – October 29, 2026 – Covista Inc. (NYSE: CVSA), America’s largest healthcare educator, today reported first quarter fiscal year 2027 results (ended Sep. 30, 2026). This quarter, the Company launched Purpose at Scale, its three-year strategy to train the next generation of healthcare professionals at industry-leading scale. Purpose at Scale is underpinned by operational excellence, platform extension, employer integration and a technology focus.
“Purpose at Scale is delivering and all four pillars of the strategy are contributing to our momentum. Total enrollment grew for the 13th consecutive quarter, powering our double-digit revenue growth and continued margin expansion. On that strength, we are raising our fiscal 2027 guidance,” said Steve Beard, Chairman and Chief Executive Officer, Covista. “The demand behind our strategy is durable, and Covista is critical infrastructure for American healthcare. We serve an urgent need in the communities where care matters most, and by doing that well, we are strategically positioned to create lasting value for our shareholders.”
Financial Highlights
Selected financial data for the three months ended Sep. 30, 2026:
●Revenue of $511.5 million increased 10.7% compared with the prior year
●Operating income of $98.0 million, compared with $85.5 million in the prior year; adjusted operating income of $106.6 million, compared with $90.3 million in the prior year
●Net income of $67.4 million, compared with $61.8 million in the prior year; adjusted net income of $75.8 million, compared with $64.9 million in the prior year
●Diluted earnings per share of $1.95, compared with $1.67 in the prior year; adjusted earnings per share of $2.19, compared with $1.75 in the prior year
●Adjusted EBITDA of $131.2 million, compared with $112.0 million in the prior year; adjusted EBITDA margin of 25.6%, compared with 24.2% in the prior year
Business Highlights
●Covista's strategic nursing collaboration with Advocate Health began enrolling students through Chamberlain University in Wisconsin. Building on that successful launch, the relationship is expanding to Chamberlain's three Chicago-area campuses.
●Chamberlain University opened its Cincinnati and Salt Lake City campuses. The Company also announced it will open its 27th campus in Nashville, which is expected to begin classes in January 2027.
●Walden University launched four new programs this quarter. Programs introduced heading into the 2026 academic year have already enrolled more than 2,000 students, demonstrating Walden’s speed to market in high-demand fields.
●Covista released new analysis showing that students at Ross University School of Medicine and American University of the Caribbean School of Medicine passed the United States Medical Licensing Examination® (USMLE®) Step 1 on their first attempt at rates
comparable to or higher than U.S. MD students with similar MCAT scores in most score bands.¹
●Covista’s performance and responsible business practices continued to earn national recognition, including TIME’s America’s Growth Leaders 2027 and World’s Best Companies 2026, and Newsweek’s America’s Greenest Companies 2027 and America’s Great
Aug 6, 2026
May 7, 2026
See how CVSA stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "CVSA Covista Inc. Common Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.